메뉴 건너뛰기
Ophthalmology
Volumn 120, Issue 2, 2013, Pages 328-333
Macular epiretinal brachytherapy in treated age-related macular degeneration (MERITAGE): Month 12 optical coherence tomography and fluorescein angiography
Author keywords

[No Author keywords available]
Indexed keywords

RANIBIZUMAB; STRONTIUM 90; YTTRIUM 90;
EID: 84873297375     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.07.091     Document Type: Article
Times cited : (17)
References (7)
  • 1
    • 61749100479 scopus 로고    scopus 로고
    • Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration
    • M.P. Ávila, M.E. Farah, A. Santos Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration Br J Ophthalmol 93 2009 305 309
    • (2009) Br J Ophthalmol , vol.93 , pp. 305-309
    • Ávila, M.P.1    Farah, M.E.2    Santos, A.3
  • 2
    • 63249111858 scopus 로고    scopus 로고
    • Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD
    • M.P. Avila, M.E. Farah, A. Santos Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD Retina 29 2009 157 169
    • (2009) Retina , vol.29 , pp. 157-169
    • Avila, M.P.1    Farah, M.E.2    Santos, A.3
  • 3
    • 84873316131 scopus 로고    scopus 로고
    • Epimacular brachytherapy for neovascular age-related macular degeneration (CABERNET): A randomized, controlled trial
    • P. Dugel, J. Bebchuk, J. Nau et al. Epimacular brachytherapy for neovascular age-related macular degeneration (CABERNET): a randomized, controlled trial Ophthalmology 120 2013 317 327
    • (2013) Ophthalmology , vol.120 , pp. 317-327
    • Dugel, P.1    Bebchuk, J.2    Nau, J.3
  • 4
    • 84863336867 scopus 로고    scopus 로고
    • Macular epiretinal brachytherapy in treated age-related macular degeneration: MERITAGE Study: Twelve month safety and efficacy results
    • P.U. Dugel, R. Petrarca, M. Bennett et al. Macular epiretinal brachytherapy in treated age-related macular degeneration: MERITAGE Study: Twelve month safety and efficacy results Ophthalmology 119 2012 1425 1431
    • (2012) Ophthalmology , vol.119 , pp. 1425-1431
    • Dugel, P.U.1    Petrarca, R.2    Bennett, M.3
  • 5
    • 79956218863 scopus 로고    scopus 로고
    • Ranibizumab and bevacizumab for neovascular age-related macular degeneration
    • CATT Research Group
    • CATT Research Group D.F. Martin, M.G. Maguire et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration N Engl J Med 364 2011 1897 1908
    • (2011) N Engl J Med , vol.364 , pp. 1897-1908
    • Martin, D.F.1    Maguire, M.G.2
  • 6
    • 0041326404 scopus 로고    scopus 로고
    • Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1
    • K.J. Blinder, S. Bradley, N.M. Bressler Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1 Am J Ophthalmol 136 2003 407 418
    • (2003) Am J Ophthalmol , vol.136 , pp. 407-418
    • Blinder, K.J.1    Bradley, S.2    Bressler, N.M.3
  • 7

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.